Wednesday, 19 October 2016

Lilly's soft tissue sarcoma treatment gets U.S. approval

(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Eli Lilly and Co's treatment for adults with advanced soft tissue sarcoma (STS).


No comments:

Post a Comment